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Abstract: Several advances have taken place since the early 2000s in the field of blood flow modelling.
These advances have been driven by the development of assist devices such as Left Ventricular
Assist Devices (LVADs), etc., and by the acceptance of in silico tests for the generation of hypotheses
concerning clot formation and lysis. We give an overview of the developments in modelling of blood
rheology and clot formation/lysis in the last 10 to 15 years. In blood rheology, advances are increasingly
supplemented by flow simulation studies. In clot formation (or coagulation), advances have taken
place in both single-scale modeling under quiescent conditions as well as in multi-scale modeling in the
presence of flow. The future will possibly see more blood flow simulations in complex geometries and,
simultaneously, development and simulation of multi-scale models for clot formation and lysis.
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1. Introduction
Constitutive models for blood play a critical role in the computational simulations used in the
design of cardiovascular devices such as ventricular assist devices (see, for instance, their role in the
Living Heart Project [1], and the SIMULIA R© Living Heart Human Model). Prediction of clot/plaque
formation and growth in regions of flow recirculation and stagnation in such devices requires reliable
models that can be integrated in computational simulations of blood flow. In an earlier review
article [2], the salient features and microstructural underpinnings of the rheology of blood and clots,
the prominent features and biochemical reactions underlying the formation, growth and lysis of
clots, and the various pathologies that are a consequence of clotting, were summarized. We also
posited an integrated framework for the study of blood flow with clot formation. In this review article,
we summarize the constitutive models in both the field of blood rheology and that of clot formation
and growth, and bring the reader abreast of the developments since the appearance of [2].
2. Advances in Modelling
Blood is a complex biochemically reacting mixture of Plasma, Lipoproteins, Red and White blood
cells, Platelets, a variety of ions, etc. Characterizing the properties of such a complex mixture is a most
daunting task. Recent, experimental investigation of blood rheology has revealed increasing complexity
with regard to the mechanisms of clotting and lysis, with the progress of time. The shear-thinning
characteristics of blood were first documented in 1965 by Charm and Kurland [3]. The viscoelastic
properties of blood were documented in 1972 by Thurston [4]; Thurston also recorded that the
viscoelastic behavior becomes less prominent at higher shear rates [5]. Blood was identified as being
thixotropic, that is, the properties of blood change with changes in the structural arrangements at the
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microscopic level with time (see Thurston [6]), and its thixotropic characteristics were measured carefully
by McMillan in 1986 [7]. Rheometry has thus led to the conclusion that blood (homogenized and
considered as a fluid) is shear-thinning, viscoelastic (in a shear rate-dependent manner), and thixotropic.
2.1. Constitutive Models for Blood
The development of constitutive models for blood has proceeded alongside the experimental
characterization of blood rheology. The classical Navier–Stokes model was used initially but once
the shear thinning behavior of blood, especially in smaller blood vessels, was recognized, the model
of choice was a non-Newtonian constitutive relation that was capable of describing shear-thinning.
This was followed in turn by more complex shear-thinning, viscoelastic models. An early study of the
flow of blood is that by Womersley [8] who obtained an analytical solution for the oscillatory pressure
gradient-driven flow of blood-modeled as a Navier–Stokes fluid through a straight pipe.
The earliest Non-Newtonian continuum model for blood was the 1-D Casson model originally
proposed for ink in 1959 [9], and shortly after adapted for blood. The popular Power-law model—usable
in 1-D flow simulations—was fitted for blood data by Liepsch and Moravec [10]. The 1-D Cross model
and the 1-D Carreau–Yasuda model—popular choices for relating the viscosity to the shear-rate in a
shear-thinning fluid—were adapted for blood by Cho and Kensey [11]. A list of other popular 1-D
Generalized Newtonian models—the Carreau model, the Powell–Eyring model, and the modified
Cross model—adapted to capture the shear-thinning behavior of blood can also be found in [11].
Viscoelastic models for blood were initially developed only in 1-D: the earliest was the
shear-thinning viscoelastic Maxwell-type model proposed by Thurston in [6]. Later attempts include
the 1-D Maxwell-type model with a shear-thinning internal variable proposed by Quemada in [12],
and that proposed by Sharp et al. in [13]. The earliest 3-D frame invariant viscoelastic model was the
Oldroyd-B model proposed by Phillips and Deutsch in 1975 [14]. This was followed by a 3-D frame
invariant model developed by Yeleswarapu in 1996 [15], and was a shear-thinning Oldroyd-B model.
The uniqueness of this model lay in the fact that the shear-thinning function for viscosity was fit to
rheometry data for human blood over a shear rate range of 0.05 s−1 to 600 s−1. A 3-D shear-thinning
Maxwell model was proposed for blood by Sun and De Kee in [16]: this model had more parameters
than the Yeleswarapu model but still had the same limitation in that the relaxation time did not depend
on the shear rate. A shear-thinning viscoelastic model with relaxation times depending on the shear
rate was first proposed by Anand and Rajagopal in 2004 [17]. This model, which is a generalization
of the Oldroyd-B model, is developed within a thermodynamic framework that recognizes that a
viscoelastic fluid can remain stress-free in several, and not just one, configurations. Owens proposed
a model in 2006 [18] using a different approach based on the theory of polymer network formation.
The Owens model had different relaxation times for RBC aggregates of different sizes: overall, though,
the model came up with a single relaxation time for blood. The difference between the models of Anand
and Rajagopal [17] and Owens [18] has been described in [19]. A second-grade fluid model which
shear-thins, but which by definition cannot exhibit stress-relaxation, was used to study pulsatile flow
of blood in a rigid artery by Massoudi and Phuoc [20]. Recently, Massoudi, Antaki and co-workers
developed a two-constituent mixture theory model for blood described in [21] which was able to
predict near-wall enrichment of platelets during flow in a channel by solving diffusion equations for
platelets along with the blood flow equations.
The model in [17] has been numerically studied in 3-D simulations by Bodnar et al. [22]: they
obtained results for steady flow in a curved and in a stenosed (stenosed = narrowed) tube. They found
that, compared to the Navier–Stokes fluid: (i) the model necessitated higher pressure drop; (ii) the
magnitude of difference in axial velocity increased with the reduction of the flow rate. Further,
compared to the shear-thinning Oldroyd-B fluid (with constant relaxation times), the shear-rate
dependent viscoelasticity played a less significant role in axial velocity difference compared to
shear-thinning. A shortcoming in the model developed by Anand and Rajagopal is that the viscosity has
a discontinuous first derivative at low shear rates, making it unsuitable for high-fidelity finite element
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methods. This shortcoming was addressed by Anand et al. [23] who developed a shear-thinning
viscoelastic fluid model that can be used with such computational schemes in complex geometries
such as bent and branched tubes through which blood is likely to flow.
2.1.1. Model of Anand et al. (2013)
The model (The material in this subsection is based on the work in [23]) in Anand et al. [23] is
that of a viscoelastic fluid with a single relaxation mechanism characterized by instantaneous elastic
response: the deformation of such a fluid is shown in Figure 1. Three configurations are seen in Figure 1:
κR(B) denotes the reference configuration of the body B, κt(B) denotes the current configuration of B
at time t, while κp(t)(B) refers to the stress-free (natural) configuration that is reached by instantaneous
elastic unloading of the body from the current configuration.
Figure 1. Configurations of a viscoelastic fluid body with instantaneous elasticity. Reproduced with
permission from Anand, M., et al., International Journal of Engineering Science; published by Elsevier,
2013 [23].
The motion of the body is a one-to-one mapping between each point (X) in the reference
configuration (κR(B)) and a corresponding point (x) in the current configuration (κt(B)) so that:
x = χκR(X, t) . (1)
Assuming the motion to be sufficiently smooth, and suppressing B in the notation for
configurations, we define the deformation gradient FκR as:
FκR =
∂χκR(B)
∂XκR
. (2)
The left Cauchy–Green stretch tensor BκR is subsequently defined as:
BκR = FκR F
T
κR
. (3)
Provided the deformation is homogeneous, the deformation gradient Fκp(t), between the
instantaneous natural configuration (see Rajagopal [24] for a detailed discussion of the notion of
natural configurations) and the current configuration, can be defined. The left Cauchy–Green stretch
tensor associated with the instantaneous elastic response from the natural configuration κp(t) is then
defined as:
Bκp(t) = Fκp(t)F
T
κp(t) . (4)
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The mapping G shown in Figure 1 is then defined by:
G = FκR→κp(t) = F
−1
κp(t)
FκR . (5)
The velocity gradient L is defined by:
L = F˙κR F
−1
κR
, (6)
where the dot represents the material time derivative. The material time derivative for a tensor variable,
say F, is given by:
DF
Dt
=
∂F
∂t
+ (gradF)v , (7)
with v being the velocity vector.
The symmetric part of L is defined as:
D =
(
L + LT
2
)
. (8)
The upper-convected Oldroyd derivative of Bκp(t),
∇
Bκp(t) is defined as:
∇
Bκp(t)= B˙κp(t) − LBκp(t) − Bκp(t)LT . (9)
Based on a thermodynamic framework that ensures that the second law of themodynamics is
met, one can systematically develop implicit rate type constitutive theories that can describe the
response of viscoelastic fluids (see Rajagopal and Srinivasa [25] for a discussion of the thermodynamic
framework and Rajagopal [26] for a discussion of implicit constitutive theories.) Using the above
notation, the Cauchy stress tensor T of the viscoelastic fluid model in Anand et al. [23] is written as:
T = −p1 + S , (10)
S = µBκp(t) + η1D , (11)
∇
Bκp(t) = −
2µ
η
(
Bκp(t) − λ1
)
, (12)
η = α
(
trBκp(t)
)−m
, m > 0 (13)
λ =
3
trB−1
κp(t)
. (14)
Here, the term η, which (along with η1 = constant) quantifies the rate of dissipation in the fluid,
contains a power-law dependence on the instantaneous elastic stretch Bκp(t); it is adapted (m > 0) to
capture the shear-thinning behavior of blood.
2.2. Models for Clot Formation and Lysis
The appearance of a clot during blood flow complicates the flow patterns in blood due to the
appearance of a new material with much higher viscosity. The traditional view of clot formation
and growth developed from in vitro biochemical experiments is the “cascade model”, wherein
clot formation is the end result of a sequence of enzymatic reactions that are facilitated on the
membrane surface of “activated platelets”. Three key biochemical changes: platelet activation
and aggregation, coagulation, and fibrinolysis: underlie the appearance, growth, and dissolution
of clots. The biochemical changes that occur in the cascade model of coagulation are detailed in
Mann [27], and they are summarized in [2] as well. An extensive review of the literature pertaining to
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mathematical/mechanistic models of the cascade model of coagulation, and the various hypotheses
explored by individual groups, can be found in [2].
The cascade model is now understood to be restricted in applicability to in vitro experiments.
The in vivo progress of blood coagulation was initially described by Orfeo et al. [28] to occur in
three stages (initiation, propagation, and termination) in three distinct compartments (extravascular
space exposed by injury, the region enclosed by the clot, and surrounding intravascular space) that
are spatially disjoint. This view has been further expanded, and it is now recognized that, in vivo,
the various reactions of blood coagulation occur at different sites on different cell surfaces which
are part of different tissues making flow, transport, and diffusion—of participating enzymes and
platelets—the important factors that link the distinct compartments into a single functional system [29].
Succinctly put, the new understanding of coagulation necessitates models that capture spatio-temporal
changes, as opposed to temporal changes alone, and those which span interactions at multiple scales
(sub-cellular coagulation reactions and fibril generation, cellular interactions of platelets with each other
and with the flow, and macro-scale vessel wall-level blood flow and reactant transport) as opposed to
single scale (macro-scale continuum level) alone. We will review the advances in single-scale modelling
of coagulation, and then proceed to review those that incorporate the new understanding.
2.2.1. Single-Scale Models
Single-scale continuum level models of coagulation consist either of reaction–diffusion equations or
simply reaction equations that govern the generation/depletion and motion of the biochemical participants
(zymogens, enzymes, enzyme complexes, and inhibitors) of coagulation. These models consist of reaction
equations in the case that motion is ignored, i.e., in quiescent conditions. Single-scale models for
coagulation consisting of reaction–diffusion equations are formulated as partial differential equations
(PDEs), whereas they are formulated as ordinary differential equations (ODEs) if only reactions are
present. Reaction–diffusion models for coagulation have the typical form:
∂[Xi]
∂t
= Di
∂2[Xi]
∂z2
+ Gi , (15)
where [Xi] is the concentration of reactant Xi, Di is the diffusion coefficient governing its motion in the
absence of flow, Gi represents the net rate of production (by generation and depletion reactions) of Xi,
and t, x are time and spatial variables, respectively. On the other hand, reaction models for coagulation
have the typical form:
d[Xi]
dt
= Gi . (16)
The most widely studied (single-scale continuum level) model for coagulation is the one
developed by Hockin et al. [30]: this model is classified as a homogeneous model in terms of its
treatment of platelets (See Diamond [31] for basis of classification of a model as homogeneous,
pseudo-homogeneous, or heterogeneous.) Kuharsky and Fogelson [32] developed a model for
coagulation that focussed on the progress of reactions which occured in a thin layer whose thickness
was determined by the flow: this model was single-scale and heterogeneous. Panteleev et al. [33]
developed a single scale heterogeneous model for coagulation that incorporated competitive
binding of fXa and fIIa on activated platelets: the model predicted that spatial propagation of
coagulation was regulated by the intrinsic pathway while the Protein C pathway facilitated the
localization of coagulation. The single scale homogeneous model of Anand et al. [34] was able to
quantitatively predict the effects of antithrombin III (ATIII) deficiency and Protein C (PC) deficiency.
Luan et al. [35] used a single scale heterogeneous model to show that mathematically-determined
points of fragility coincided with clinical data, and thus advocated the use of such models for
determining therapeutic targets. Chatterjee et al. [36] extended the model of [30] and developed
a single-scale pseudo-homogeneous model that captured the clot initiation that occurred in blood even
when treated with corn trypsin inhibitor (Corn trypsin inhibitor is used to block the contact pathway
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of coagulation). Susree and Anand [37] combined elements of the models in [30,32,34] to come up
with a single scale pseudo-homogeneous model which showed that inhibition of platelet activation by
other platelets had a much more significant effect on thrombin production than inhibition of platelet
activation by thrombin.
2.2.2. Multi-Scale Models
While single-scale computational models using systems of ODEs and PDEs have become the
main stay of in silico tests to improve diagnostics of coagulation, and also in pharmacodynamic
studies to determine drug efficacy and suggest targets for drugs, the future of computational modeling
(given the advances in the understanding of coagulation) is likely to involve models that incorporate
convection, diffusion, and spatial distribution of enzymes [38]. By extension, models which incorporate
cellular-level information as well, and illustrated using suitably advanced simulations are likely to
play a more important role. In the last few years, work has focused on understanding the role of flow
and transport in integrating the different compartments of the hemostatic response. We will briefly
review the work that has incorporated the role of flow on clot growth, and vice versa, rather than on
individual studies (usually performed in microfluidic devices) that aim to elucidate the effect of flow
on each reaction or event (such as platelet aggregation).
Bodnar and Sequeira [39] numerically simulated the framework of models (albeit, slightly
simplified) that was posited by Anand et al. [2]: they reported results for the growth of a more
viscous clot during blood flow over a finite surface injury on the walls of a cylindrical pipe. This work
was preliminary, and was meant to validate the numerical scheme and also the correctness of results
obtained using the framework of models. The final results using the complete framework of models
in [2] were presented in Sequeira and Bodnar [40]. However, because the models in [2,34] did not have
a separate term to track platelets (a limitation that was addressed in [37]), the results of Sequeira and
Bodnar [40] do not contain information on the distribution of platelets in the clots, nor on how platelet
distribution affects movement of enzymes within the clot: i.e., they do not contain information at the
cellular scale, although they incorporate information at sub-cellular and continuum scales. Information
at the cellular (platelet) scale, but not the effect of blood/clot rheology, can be found in the studies
mentioned hereafter.
Leiderman and Fogelson [41] extended the work of Kuharsky and Fogelson [32], and used platelet
concentration profiles in simulations of spatio-temporal platelet-thrombus growth in the presence of
flow: they found that increasing shear rate led to increased platelet deposition (and thrombus growth)
only if inlet platelet distribution was non-uniform (with pronounced near-wall excess of platelets).
Further, apart from thrombus size, density of bound platelets within the thrombus were highest for
the highest shear rate (at which the near-wall platelet concentration was also highest). This work was
extended to study the effect of hindered transport of proteins within the thrombus in [42]. A review of
these works can be found in Leiderman and Fogelson [43]. A more expansive review of multi-scale
models by Fogelson and Neeves [44] includes the above works as part of a spectrum of modeling and
experimental work aimed at describing the role of fluid mechanics in clot formation and stability.
Separately, Wu et al. [45] developed and simulated growth of a thrombus in a Navier–Stokes
fluid using a set of 10 convection–reaction–diffusion equations which allowed for irregular thrombus
shape, alteration of flow field due to growth of the thrombus, and thrombus embolization due to
shear. These extensions are important when simulating blood flow over blood-wetted devices, and the
authors presented illuminating results for the growth of thrombus on an injured blood vessel in vivo,
and in a micro-crevice in vitro.
Xu et al. [46] developed a multi-scale model for platelet and red blood cell (RBC) aggregation
in two-dimensional flow of a Navier–Stokes fluid with sub-cellular continuum level biochemical
reactions. They used a discrete stochastic Cellular Potts Method (CPM) to track the movement of
platelets and RBCs, and the homogeneous model of Jones and Mann [47] for the biochemical reactions.
Their simulations reproduced some experimentally observed features of platelet thrombi such as
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quantitative dependence of thrombus growth rate on blood flow rate, and heterogeneity of thrombus
structure. Xu et al. [48] extended the model to use the more comprehensive biochemistry model in [30]
and included platelet-binding reactions from [32]: they obtained a result consistent with experimental
data in that factor VII played an important role in early-stage thrombus development. These, and other
single-scale, two-scale, and multi-scale studies were reviewed by Xu et al. [49]. A more recent review
by Bessonov et al. [50] cites the presence of multi-scale methods apart from the CPM-PDE method
used by Xu et al. [46] to model cellular interactions in blood plasma, and particularly highlights the
results obtained using the Dissipative Particle Dynamics-Partial Differential Equation (DPD-PDE)
method for flow of plasma with platelets and RBCs.
3. Discussion
We have reviewed the advances in modelling of blood rheology, and of clot formation and
lysis, since the appearance of the article [2]. While some new models in blood rheology (notably the
ones in [18,20,23]) have appeared, the thrust of development is in simulation of such models in the
complex geometries of the vasculature/medical devices through which blood flows. With regard to
clot formation, the acceptance of in silico tests for the generation of hypotheses by an influential section
of the biochemical community (see Mann [51]) has meant increasingly comprehensive single-scale
models of coagulation (notably the ones in [36,37]). Simultaneously, with our understanding of in vivo
coagulation evolving from the “cascade” model into a ‘three-stage multi-scale process made functional
by flow’, multi-scale models of coagulation have been developed (notably the ones in [40,41,48]),
simulated in the presence of flow, and their predictions verified with experimental hypotheses.
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